Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 60.00% vs 400.00% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -100.00% vs 0.00% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 3,401.64% vs 154.17% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 5,720.00% vs -78.26% in Mar 2024
Compare Balance Sheet Results of Bacil Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
13.97
25.00
-11.03
-44.12%
Share Warrants & Outstandings
Total Reserve
11.46
17.16
-5.70
-33.22%
Shareholder's Funds
25.43
42.16
-16.73
-39.68%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.37
-0.37
-100.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.37
-0.37
-100.00%
Deferred Tax Assets / Liabilities
-0.05
0.93
-0.98
-105.38%
Other Long Term Liabilities
0.00
1.62
-1.62
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
-0.05
2.93
-2.98
-101.71%
Current Liabilities
Trade Payables
0.00
33.87
-33.87
-100.00%
Other Current Liabilities
0.00
24.10
-24.10
-100.00%
Short Term Borrowings
0.16
39.62
-39.46
-99.60%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
0.17
97.59
-97.42
-99.83%
Total Liabilities
25.55
142.68
-117.13
-82.09%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.06
23.32
-23.26
-99.74%
Less: Accumulated Depreciation
0.06
0.00
0.06
0.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.00
23.32
-23.32
-100.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
15.07
-15.07
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
21.36
7.09
14.27
201.27%
Long Term Loans & Advances
1.28
11.98
-10.70
-89.32%
Other Non Current Assets
0.00
18.25
-18.25
-100.00%
Total Non-Current Assets
22.64
75.70
-53.06
-70.09%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.00
25.62
-25.62
-100.00%
Sundry Debtors
0.00
15.54
-15.54
-100.00%
Cash and Bank
2.86
17.66
-14.80
-83.81%
Other Current Assets
0.00
3.97
-3.97
-100.00%
Short Term Loans and Advances
0.05
4.18
-4.13
-98.80%
Total Current Assets
2.91
66.97
-64.06
-95.65%
Net Current Assets (Including Current Investments)
2.74
-30.62
33.36
108.95%
Total Current Assets Excluding Current Investments
2.91
66.97
-64.06
-95.65%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
25.55
142.68
-117.13
-82.09%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
0.16
39.99
-39.83
-99.60%
Book Value per share (adjusted)
18.20
16.86
1.34
7.95%
Annual - Borrowings
Borrowings 0.16 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 60.00% vs 400.00% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 0.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -100.00% vs 0.00% in Mar 2024
Annual - Investments
Investments 21.36 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 3,401.64% vs 154.17% in Mar 2024
Annual - Current Assets
Current Assets 2.91 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 5,720.00% vs -78.26% in Mar 2024
